Exploration of the Application of the Performance Excellence Model in Program Management of Isotope Pharmaceutical Center Projects

Recently, China Isotope & Radiation Corporation, a leading enterprise in the domestic radiopharmaceutical industry, focusing on practicing the "Six Controls and Seven Zeros" and the concept of refined management throughout the entire engineering construction process, conducted an in-depth review of the lessons learned from 30 completed and operational projects, and systematically established and comprehensively promoted a performance excellence-oriented management and control system for the isotope pharmaceutical center project portfolio. This innovative practice has effectively addressed the management and control pain points of pharmaceutical center projects being "small, scattered, and remote," and has pressed the "accelerator" for the high-quality deployment of the national radiopharmaceutical supply network.

With the accelerating pace of nuclear medicine innovation and capacity upgrading since the "14th Five-Year Plan" period, China Isotope & Radiation Corporation has cumulatively deployed 37 pharmaceutical center projects, with business coverage spanning... Faced with the unique challenges of small individual scale, scattered geographical distribution, and remote project site selection, the traditional decentralized single-project management model has become difficult to adapt to the new requirements of high-quality development. To this end, China Isotope & Radiation Corporation deeply integrated the performance excellence management model with engineering construction project management, established the overall development approach of "standardization as the foundation, intensification for efficiency improvement, lean management and control, and continuous enhancement," and formally treated the pharmaceutical centers across the country as an organic project portfolio for comprehensive coordinated management.

In terms of the top-level design and implementation of the specific management and control system, China Isotope & Radiation Corporation focused on advancing four core pillars: through the formal preparation and issuance of the "Standardized Construction Plan for Isotope Pharmaceutical Center Projects," six core dimensions spanning the entire life cycle were precisely distilled, thoroughly eliminating management standard differences across regions and projects; firmly implementing the strategy of "strengthening the headquarters and intensifying management and control," comprehensively promoting the professional "entrusted management" model, with the headquarters team directly delivering mature processes and resources, achieving nationwide intensive allocation of management resources and an overall leap in team operational capability; centering on the four core development goals of "controlling over-budget, shortening schedule, ensuring quality, and expediting certification," comprehensively establishing a rigid management and control mechanism covering limit design, a four-tier planning system, dual-track quality compliance, and advance intervention in certification, extending horizontally to all sides and vertically to the bottom; and establishing a performance indicator evaluation system covering all elements of investment, schedule, quality, safety, and compliance, along with a PDCA closed-loop improvement ecosystem, continuously driving the spiral escalation of project portfolio management effectiveness.

This management innovation has not only powerfully ensured the rapid, compliant, and efficient completion and commissioning of pharmaceutical centers across various regions, providing stable and reliable radiopharmaceutical supply guarantees for the vast number of clinical patients nationwide, but has also provided a highly valuable excellent practice reference sample for the management of similar "small, scattered, and remote" project portfolios in the field of nuclear technology applications.

Disclaimer: Information republished from partner media, institutions or other websites is provided for reference and communication purposes only. It does not imply endorsement of its views or verification of its accuracy. Please contact us if any content infringes rights or requires correction.